Summary
A prospective study was designed to investigate anaerobic bacteremias and evaluate their incidence and significance in a general hospital. One or more blood cultures positive for anaerobic microorganisms were analyzed from each of a total of 61 patients hospitalized between January 1988 and April 1992, in accordance with an established protocol. The clinical repercussions of bacteremia were also analyzed. Two percent of blood cultures were positive for anaerobes, with an incidence of 0.6 cases per 1000 hosphitalized patients. The most frequently isolated anaerobes were Bacteroides fragilis and Clostridium perfringens. Intraabdominal disease was the route of entry in 50% of the patients. A death rate of 37.3 % was mostly attributed to B. fragilis. Hospitalization in the surgical department, nosocomial acquisition, previous surgery, critical initial clinical status and the presence of complications were significantly associated with increased death rates. No significant differences were found in the clinical course between patients whose antibiotic treatment was judged adequate and those for whom it was considered inadequate. The frequency and incidence of anaerobic bacteremia was low in our hospital. The well-known clinical and epidemiological characteristics of these infections facilitates their prompt diagnosis and empirical treatment with antibiotics of proven effectiveness against anaerobes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Balows A, Hansler WJ Jr, Herrman KL, Isemberg HD, Shadomy HJ (1991) Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, DC
Bartlett JG (1992) Infections caused by anaerobic bacteria. In: Gorbach SL, Bartlett JG, Blacklow NR (eds) Infectious diseases. Saunders, Philadelphia, pp 1555–1568
Berenguer J, Cuadros JA, Betriu C, Muñoz P, Moreno JJ (1989) Bacteriémia por Bacteroides. Un análisis de 50 episodios. Enf Infec Microbiol Clin 7:307–310
Bieluch VM, Cuchural GJ, Snydman DR, Gorbach SL, Tally FP (1987) Clinical importance of cefoxitin-resistant Bacteroides fragilis isolates. Diagn Microbiol Infect Dis 7:119–126
Bouza E, Reig E, Garcia de la Torre M, Rodriguez M, Romero J, Cercenado E, Baquero F (1985) Retrospective analysis of two hundred and twelve cases of bacteremia due to anaerobic microorganisms. Eur J Clin Microbiol 4:262–267
Bouza E, Garcia de la Torre M (1991) Bacteriemia y endocarditis por anaerobios. In: Garcia Rodriguez JA (ed) Infecciones por anaerobios. Prous, Barcelona, pp 39–51
Brook I (1989) Anaerobic bacterial bacteremia: 12-year experience in two military hospitals. J Infect Dis 160:1071–1075
Brook I (1991) In vitro susceptibility and in vivo efficacy of various antimicrobial agents against the Bacteroides fragilis group. Rev Infect Dis 13:1170–1180
Casciato DA, Rosenblart JE, Bluestone R, Gooldberg LS, Finegold SM (1979) Susceptibility of isolates of Bacteroides to the bactericidal activity of normal human serum. J Infect Dis 140:109–113
Cooper GS, Havlir DS, Shlaes DM, Salata RA (1990) Polimicrobial bacteremia in the late 1980s: predictors of outcome and review of the literature. Medicine 69:114–123
Dorsher CW, Rosenblart JE, Wilson WR, Ilstrup DM (1991) Anaerobic bacteremia: decreasing rate over 1 15-year period. Rev Infect Dis 13:633–636
Elting LS, Bodey GP, Fainstein V (1986) Polimicrobial septicemia in the cancer patient. Medicine 65:218–225
Fainstein V, Elting LS, Bodey GP (1989) Bacteremia caused by non-sporulating anaerobes in cancer patients. Medicine 68:151–162
Finegold SM (1990) Anaerobes: problems and controversies in bacteriology, infections, and susceptibility testing. Rev Infect Dis 12 [Suppl 2]:S223-S230
García Rodriguez JA, Garcia Sanchez JE (1990) Evolution of antimicrobial susceptibility in isolates of the Bacteroides fragilis group in Spain. Rev Infect Dis 12 [Suppl 2]:S142-S151
Gómez J, Botia F, Moldenhauer F, Ruiz J, Sánchez F, Canteras M, Hernández J, Villaescusa M (1989) Características epidemiológicas de las bacteriemias en un hospital general. Estudio prospective, 1987. Todo Hospital 60:80–82
Gómez J, Martinez Ros C, Baños V, Sempere M, Garcia Estañ J, Valdés M (1991) Perspectivas actuales del tratamiento de las septicemias. Rev Esp Quimioter 4:115–120
Gómez J, Ros J, Ruiz Gómez J, Canteras M, Valdés M, Martin Luengo F (1991) Comparison of the efficacy of three different treatment with imipenem versus classical clindamycin plus tobramycin in experimental peritonitis. J Chemother 3:367–371
Lombardi DP, Engleberg NC (1992) Anaerobic bacteremia: incidence, patient characteristics, and clinical significance. Am J Med 92:53–60
McCabe WR, Jackson GG (1962) Gram-negative bacteriemia. I. Ecology and etiology. Arch Intern Med 110:847–855
Nitta AT, Kuritzkes DR (1991) Anaerobic bacteremia: declining rate over a 15-year period. Rev Infect Dis 13:1255
Pélaez MT, Cercenado E, Rodriguez-Creixems M, Bouza E (1991) Resistance of anaerobic bacteria to antimicrobial agents. Rev Infect Dis 13:183–187
Solomkin JS, Dellinger EP, Christou NV, Busttil RW (1990). Results of multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections. Ann Surg 212:581–591
Terpenning MS (1989) Anaerobic bacteremis in the elderly. Gerontology 35:130–136
Topiel MS, Simon GI (1986) Pectococcaceae bacteremia. Diagn Microbiol Infect Dis 4:109–117
Vázquez F, Méndez FJ, Pérez F, Mendoza MC (1987) Anaerobic bacteremia in a general hospital: retrospective five-year analysis. Rev Infect Dis 9:1038–1043
Winston DJ, Murphy W, Young LS (1980) Piperacillin therapy for serious bacterial infections. Am J Med 69:255–261
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gómez, J., Baños, V., Ruiz, J. et al. Clinical significance of anaerobic bacteremias in a general hospital. Clin Investig 71, 595–599 (1993). https://doi.org/10.1007/BF00184481
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00184481